Avacta Group Seeks AIM Block Listing for 6.5 Million Shares

PUBLISHED: 08 May 2025 @ 18:18 | Comments (0) | More info about Fiona Craig

Avacta Group plc (LSE:AVCT) has applied for a block listing of 6,500,000 ordinary shares on the AIM market to facilitate the trading of shares following the exercise of options under its Long-Term Incentive Plan (LTIP) and Employee Share Option Scheme (ESOS). The block listing is expected to become effective on May 14, 2025, enabling the issuance and trading of new ordinary shares while maintaining parity with existing shares. This strategic move demonstrates Avacta’s commitment to enhancing its market presence and providing shareholders with transparency on share capital changes.

About Avacta Group plc

Avacta Therapeutics is a clinical-stage life sciences company specializing in the development of innovative, targeted oncology drugs. Utilizing its proprietary pre|CISION® platform, Avacta aims to improve cancer therapies by delivering tumor-specific protease-activated drugs, thereby reducing damage to healthy tissues. The company’s pipeline includes pre|CISION® peptide drug conjugates and Affimer® drug conjugates, offering distinct advantages over traditional antibody drug conjugates.

Average Trading Volume: 1,924,918 shares
Technical Sentiment Indicator: Sell
Market Capitalization: £130.4 million

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Ltd. ADVFN Ltd does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.